JONATHAN NIX: Open Payments
NPI 1811087299 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,362 in 102 payments from 18 companies in 2025. Trend: 2023 $1,293 · 2024 $1,947 · 2025 $2,362
Food & beverage: $2,362
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $355 |
| Janssen Biotech, Inc. | 19 | $331 |
| GENZYME CORPORATION | 10 | $295 |
| Galderma Laboratories, L.P. | 11 | $234 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $180 |
| Novartis Pharmaceuticals Corporation | 6 | $168 |
| Arcutis Biotherapeutics, Inc. | 2 | $142 |
| LEO Pharma Inc. | 4 | $106 |
| PFIZER INC. | 5 | $97 |
| Incyte Corporation | 3 | $84 |
Products named: TREMFYA, DUPIXENT, RINVOQ, NEMLUVIO, ILUMYA, COSENTYX, Zoryve, SKYRIZI.
Industry payments across GA — which companies pay providers there.
